Income statement, balance sheet and cash flow statement for the last 2 fiscal years, taken from the XBRL data Adia Nutrition, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2025
FY2025
Revenue
0.01
0.7
Cost of revenue
0
0.51
Gross profit
0
0.19
Research and development
0
0.03
Selling and marketing
0.04
0.08
General and administrative
0.14
0.48
Operating expenses
0.18
0.56
Operating income
-0.17
-0.37
Interest expense
0.01
0.03
Interest income
0
0
Other non-operating income
-0.01
-0.03
Pre-tax income
-0.18
-0.4
Income tax
0
0
Net income
-0.18
-0.4
EBITDA
-0.17
-0.36
EPS, basic
0.00
0.00
EPS, diluted
0.00
0.00
Shares, basic (weighted)
91.7
93.6
Shares, diluted (weighted)
91.7
93.6
Balance sheet
FY2025
FY2025
Cash and equivalents
0.01
0.08
Receivables
0
0.03
Inventory
0.21
0.03
Other current assets
0.05
0.02
Total current assets
0.26
0.16
Property, plant and equipment
0.02
0.03
Lease right-of-use assets
0.16
0.11
Intangible assets
0.01
0
Total assets
0.67
0.59
Accounts payable
0
0
Deferred revenue
0
0.01
Total current liabilities
0.08
0.75
Lease liabilities
0.1
0.05
Total liabilities
0.64
0.85
Paid-in capital
15.4
15.5
Retained earnings
-15.6
-16
Shareholders' equity
0.03
-0.26
Total equity
0.03
-0.26
Total liabilities and equity
0.67
0.59
Cash flow statement
FY2025
FY2025
Net income
-0.18
-0.4
Depreciation and amortization
0
0
Stock-based compensation
0.03
0.04
Change in receivables
0
-0.03
Change in payables
0
-0
Cash from operations
-0.34
-0.18
Capital expenditures
-0.02
-0.01
Cash from investing
-0.03
-0.03
Stock issued
0.03
0.07
Cash from financing
0.37
0.28
Net change in cash
0.01
0.07
Free cash flow
-0.36
-0.19
Interest paid
0
0
Income taxes paid
0
0
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $0.15 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
27.4%
Gross profit / revenue.
Operating margin
-52.3%
Operating income / revenue.
EBITDA margin
-51.7%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-56.5%
Pre-tax income / revenue.
Net margin
-56.5%
Net income / revenue.
FCF margin
-27.5%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-25.6%
Cash from operations / revenue.
Return on assets (ROA)
-62.7%
Net income / average total assets.
R&D / revenue
4.2%
Research and development expense / revenue.
Stock-based pay / revenue
6.0%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
1.9%
Capital expenditures / revenue.
D&A / revenue
0.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
10,880.0%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
8,636.0%
Gross profit vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-1,109.0%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-10.7%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
2.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.22x
Current assets / current liabilities.
Quick ratio
0.15x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.11x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.00
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
$0.00
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.01
Revenue / diluted weighted shares.
FCF per share
-$0.00
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.00
Cash from operations / diluted weighted shares.
Book value per share
-$0.00
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
20.2x
Market cap / revenue.
EV/Sales
20.1x
Enterprise value / revenue.
FCF yield
-1.4%
Free cash flow / market cap.
Earnings yield
-2.8%
Net income / market cap (the inverse of P/E).
What was Adia Nutrition, Inc.'s revenue in fiscal 2025?
Adia Nutrition, Inc. reported revenue of $700.5K for fiscal 2025, 10,879.7% higher than the year before.
Was Adia Nutrition, Inc. profitable in fiscal 2025?
No. It reported a net loss of $395.5K.
How much free cash flow did Adia Nutrition, Inc. generate in fiscal 2025?
Cash from operations of $179.2K minus capital expenditures of $13.2K left free cash flow of -$192.4K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.